| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +54.0% |
| R&D Expense | $8K | -66.4% |
| SG&A Expense | $188K | -27.5% |
| Operating Income | -$235K | +38.4% |
| Net Income | -$1.0M | +15.4% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13K | -37.9% |
| Current Assets | $13K | -37.9% |
| Total Assets | $771K | +31.2% |
| Current Liabilities | $10.7M | +10.3% |
| Stockholders' Equity | -$9.9M | -9.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$381K | -4.4% |
| Investing Cash Flow | -$191K | — |
| Financing Cash Flow | $564K | +138.4% |